NCT04315090 is a clinical trial in Degenerative Spinal Arthritis, sponsored by Mayo Clinic.

Who is sponsoring NCT04315090?

NCT04315090 is sponsored by Mayo Clinic.

What condition does NCT04315090 study?

NCT04315090 studies Degenerative Spinal Arthritis, Cervical Myelopathy, Spinal Stenosis.

Is NCT04315090 still recruiting?

NCT04315090 is currently withdrawn. Last updated 10 December 2021.

Last reviewed 2021-12-10 · How we verify

NCT04315090

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Post-surgical Outcomes Measure Using the ERAS Protocol for Posterior Cervical Decompression and Fusion

Withdrawn Last updated 10 December 2021

What this trial tests

trial in Degenerative Spinal Arthritis. Withdrawn.

Timeline

9 October 2020

Primary endpoint
1 May 2022

1 December 2022

Quick facts

Lead sponsor	Mayo Clinic
Status	Withdrawn
Study type	OBSERVATIONAL
Start date	9 October 2020
Primary completion	1 May 2022
Estimated completion	1 December 2022

Conditions studied

Degenerative Spinal Arthritis — all drugs for Degenerative Spinal Arthritis →
Cervical Myelopathy — all drugs for Cervical Myelopathy →
Spinal Stenosis — all drugs for Spinal Stenosis →

Sponsor

Mayo Clinic

Who can join

Adults 18 to 89, any sex, with Degenerative Spinal Arthritis or Cervical Myelopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research study is being conducted to help improve the pre-operative, intra-operative, and post-operative course for patients and enhance recovery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Mayo Clinic trials

Trials by the same sponsor.

NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04315090 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
Last refreshed: 10 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04315090.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing